Celsion Corporation (CLN) to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009
11/6/2009 3:17:02 PM
More...
|
Celsion Corporation (CLN) and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
10/27/2009 10:20:14 AM
More...
|
Investigator Meetings Completed in Japan and China for Celsion Corporation (CLN)'s Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
10/20/2009 9:30:43 AM
More...
|
Celsion Corporation (CLN)'s Global Phase III ThermoDox(R) Trial Expands to Malaysia and the Philippines
10/19/2009 9:00:34 AM
More...
|
Celsion Corporation (CLN)'s Global Phase III ThermoDox(R) Trial Approved by SFDA in China
10/15/2009 8:22:15 AM
More...
|
Celsion Corporation (CLN) Announces $7.1 Million Registered Direct Offering
9/28/2009 9:39:49 AM
More...
|
Celsion Corporation (CLN) Initiates Enrollment Awareness Program for Pivotal Phase I/II DIGNITY Trial of ThermoDox(R) in Patients with Recurrent Chest Wall (RCW) Breast Cancer
9/28/2009 8:30:44 AM
More...
|
Royal Philips Electronics N.V. (PHG) and Celsion Corporation (CLN) Advance Development of ThermoDox(R) and MR-Guided HIFU
9/23/2009 7:01:03 AM
More...
|
Data Safety Monitoring Board Recommends Continuation of Celsion Corporation (CLN)'s Phase III ThermoDox(R) Study for Primary Liver Cancer
9/21/2009 7:06:33 AM
More...
|
Celsion Corporation (CLN)'s ThermoDox(R) Study for RCW Breast Cancer Aired on ABC and CBS Affiliate Stations
9/16/2009 9:28:39 AM
More...
|
|